Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 1—January 2018
Dispatch

High Seroprevalence of Jamestown Canyon Virus among Deer and Humans, Nova Scotia, Canada

Glenn Patriquin, Michael Drebot, Teri Cole, Robbin Lindsay, Emily Schleihauf, B. Lynn Johnston, Kristina Dimitrova, Maya Traykova-Andonova, Angela Mask, David Haldane, and Todd F. HatchetteComments to Author 
Author affiliations: Nova Scotia Health Authority, Halifax, Nova Scotia, Canada (G. Patriquin, B.L. Johnston, D. Haldane, T.F. Hatchette); Dalhousie University, Halifax (G. Patriquin, B.L. Johnston, D. Haldane, T.F. Hatchette); Public Health Agency of Canada, Winnipeg, Manitoba, Canada (M. Drebot, R. Lindsay, K. Dimitrova, M. Traykova-Andonova); Nova Scotia Department of Health and Wellness, Halifax (T. Cole); Public Health Agency of Canada, Ottawa, Ontario, Canada (E. Schleihauf, A. Mask).

Main Article

Table 2

Human Jamestown Canyon virus seropositivity by sex and age, Nova Scotia, Canada

Characteristic No. tested No. (%) positive Adjusted proportion (95% CI) p value*
Sex 0.013
M 151 51 (33.8) 26.8 (19.9–35.0)
F
150
30 (20.0)
14.4 (9.3–21.5)
Age group, y 0.024
10–19 43 6 (14.0) 10.8 (4.0–25.8)
20–29 54 13 (24.1) 20.4 (11.0–34.5)
30–39 52 12 (23.1) 14.1 (6.9–26.7)
40–49 60 15 (25.0) 20.4 (1.6–33.3)
50–59 61 21 (34.4) 27.8 (17.1–41.7)
60–64
31
14 (45.2)
33.0 (17.7–53.0)
District Health Authority 0.004
1 81 39 (48.2) 48.2† (37.4–59.1)
2–8 115 26 (22.6) 22.6† (15.8–31.4)
9
105
16 (15.2)
15.2† (9.5–23.5)

Total no. 301 81 (26.9) 20.6 (16.0–25.9)

*Pearson χ2 for test by DHA; corrected Pearson χ2 for test by sex; logistic regression test for trend by age group.
†Adjustment was unnecessary for estimates made by the DHA because weighting was done by this authority.

Main Article

Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external